KOMBIGLYZE XR is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Astrazeneca Pharmaceuticals Lp. The primary component is Saxagliptin Hydrochloride; Metformin Hydrochloride.
| Product ID | 0310-6145_1e7f37ed-134a-456b-a759-dffd0dbf1360 |
| NDC | 0310-6145 |
| Product Type | Human Prescription Drug |
| Proprietary Name | KOMBIGLYZE XR |
| Generic Name | Saxagliptin And Metformin Hydrochloride |
| Dosage Form | Tablet, Film Coated, Extended Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2014-12-04 |
| Marketing Category | NDA / NDA |
| Application Number | NDA200678 |
| Labeler Name | AstraZeneca Pharmaceuticals LP |
| Substance Name | SAXAGLIPTIN HYDROCHLORIDE; METFORMIN HYDROCHLORIDE |
| Active Ingredient Strength | 5 mg/1; mg/1 |
| Pharm Classes | Dipeptidyl Peptidase 4 Inhibitor [EPC],Dipeptidyl Peptidase 4 Inhibitors [MoA],Biguanide [EPC],Biguanides [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2014-12-22 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA200678 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2015-01-04 |
| Marketing Category | NDA |
| Application Number | NDA200678 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2015-01-04 |
| Ingredient | Strength |
|---|---|
| SAXAGLIPTIN HYDROCHLORIDE | 5 mg/1 |
| SPL SET ID: | fbd25da4-ebe6-45c9-beb8-93523d11a0b4 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0310-6125 | KOMBIGLYZE | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE |
| 0310-6135 | KOMBIGLYZE | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE |
| 0310-6145 | KOMBIGLYZE | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() KOMBIGLYZE 85141038 4301782 Live/Registered |
ASTRAZENECA AB 2010-09-29 |